glp 1 drugs and alcohol consumption GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute Not just obesity: GLP-1 receptor
Description
doi: 10.1016/j.jhepr.2025.101363, 21
Fluids Barriers CNS 2019
(2022) 23(5):e13428
A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity
Statistical Analysis Science and data through a recent survey in the US constantly suggests that surgery always outperforms GLP-1s, with the NIH comparison of surgical vs non-surgical revealing that patients who underwent bariatric surgery presented better weight loss progress and comorbidity resolutions
